Improved local control with higher doses of radiation in large-volume stage III non-small-cell lung cancer Journal Article


Authors: Rengan, R.; Rosenzweig, K. E.; Venkatraman, E.; Koutcher, L.; Fox, J. L.; Nayak, R.; Amols, H.; Yorke, E.; Jackson, A.; Ling, C. C.; Leibel, S. A.
Article Title: Improved local control with higher doses of radiation in large-volume stage III non-small-cell lung cancer
Abstract: Purpose It has been suggested that larger tumor volume is associated with poor survival in patients with non-small-cell lung cancer (NSCLC). We investigated whether high-dose radiation improved local control in patients with large-volume Stage III NSCLC. Methods and materials Seventy-two patients with Stage III NSCLC and gross tumor volumes (GTV) of greater than 100 cc were treated with three-dimensional conformal radiotherapy (3D-CRT). Patients were divided into two groups: those treated to less than 64 Gy (37 patients) and those treated to 64 Gy or higher (35 patients). Results The 1-year and 2-year local failure rates were 27% and 47%, respectively, for Stage III patients treated to 64 Gy or higher, and 61% and 76%, respectively, for those treated to less than 64 Gy (p = 0.024). The median survival time for patients treated to 64 Gy or higher was 20 months vs. 15 months for those treated to less than 64 Gy (p = 0.068). Multivariate analysis revealed that dose and GTV are predictors of local failure-free survival. A 10 Gy increase in dose resulted in a 36.4% decreased risk of local failure. Conclusions Our data suggest that administration of higher doses using 3D-CRT improves local control in Stage III NSCLC patients with large GTVs. © 2004 Elsevier Inc.
Keywords: adult; cancer survival; controlled study; aged; middle aged; treatment failure; major clinical study; cisplatin; cancer radiotherapy; radiation dose; cancer staging; neoplasm staging; lung toxicity; tumor volume; lung non small cell cancer; carcinoma, non-small-cell lung; lung neoplasms; radiotherapy dosage; radiotherapy; patient monitoring; age factors; prediction; gastrointestinal toxicity; tumors; dosimetry; multivariate analysis; local control; radiotherapy, conformal; regression analysis; computer assisted radiotherapy; esophagus disease; radiation pneumonia; non-small-cell lung cancer; cells; conformal radiotherapy; dose escalation; humans; human; priority journal; article; 3d-conformal radiotherapy; gross tumor volumes (gtv)
Journal Title: International Journal of Radiation Oncology, Biology, Physics
Volume: 60
Issue: 3
ISSN: 0360-3016
Publisher: Elsevier Inc.  
Date Published: 2004-11-01
Start Page: 741
End Page: 747
Language: English
DOI: 10.1016/j.ijrobp.2004.04.013
PROVIDER: scopus
PUBMED: 15465190
DOI/URL:
Notes: Int. J. Radiat. Oncol. Biol. Phys. -- Cited By (since 1996):82 -- Export Date: 16 June 2014 -- CODEN: IOBPD -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Venkatraman Ennapadam Seshan
    382 Seshan
  2. Ramesh Rengan
    8 Rengan
  3. Jana Lauren Fox
    7 Fox
  4. Steven A Leibel
    252 Leibel
  5. Andrew Jackson
    253 Jackson
  6. Ellen D Yorke
    450 Yorke
  7. Howard I Amols
    157 Amols
  8. C Clifton Ling
    331 Ling
  9. Reena R Nayak
    3 Nayak